Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.60 |
| ▸ | SCN9A | Q15858 | 10/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18232171 | 0.89 | ADORA2A (0.51) | ADORA2AKDM4EALDH1A1NUDT1 | |
| SCHEMBL16520903 | 0.89 | ADORA2A (0.55) | ADORA2AKDM4EALDH1A1NUDT1 | |
| SCHEMBL25877803 | 0.86 | TNKS (0.51) | ADORA2ACNR1CNR2KDM4EALDH1A1 | |
| SCHEMBL18232158 | 0.80 | ADORA2A (0.42) | ADORA2AHTR2BKDM4EALDH1A1MAPK10 | |
| SCHEMBL22113578 | 0.79 | ADORA2A (0.40) | ADORA2AKDM4EALDH1A1NUDT1 | |
| SCHEMBL28872940 | 0.79 | ADORA2A (0.66) | ADORA2ASCN9AKDM4EALDH1A1MAPK10 | |
| SCHEMBL18232159 | 0.78 | ADORA2A (0.46) | ADORA2AKDM4EALDH1A1NUDT1 | |
| SCHEMBL26936075 | 0.78 | ADORA2A (0.39) | ADORA2AKDM4EALDH1A1NUDT1 | |
| SCHEMBL25054659 | 0.76 | CCNE2 (0.46) | ALDH1A1 | |
| SCHEMBL28232225 | 0.76 | ADORA2A (0.67) | ADORA2ASCN9AALDH1A1MAPK10MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192669-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192669-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | ACHE, OR51E2, L1CAM | ADORA2A 139/4885SCN9A 1492/4885CNR1 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.